Washington HB 1725: Increasing access to biosimilar medicines.

Status: By resolution, reintroduced and retained in present status. (as of 2026-01-12)

State: Washington · Session: 2025-2026 · Bill: HB 1725

Sponsors: Thai, Duerr, Macri, Parshley, Shavers

View Washington HB 1725 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.